RCEP trade agreement threatens access to affordable medicines for half the world’s population
As the RCEP trade deal is negotiated this week in New Zealand, MSF appeals for the removal of harmful intellectual property provisions that could raise medicine prices. Read more
R&D REPORT: LIVES ON THE EDGE
MSF illustrates how our staff and patients are impacted by the way biomedical R&D is conducted today, and looks at a broad range of policies aimed at changing this dynamic.
READ THE REPORT
TPP: A BAD DEAL FOR MEDICINE
After 5 years of secret negotiations the US and 11 other Pacific countries have reached an agreement on the full text of the TPP which will now be submitted to national processes for final signature and ratification. Read MSF's reaction.
HANDS OFF OUR MEDS
Join us in urging Indian Prime Minister Modi to protect India’s production of lifesaving affordable generic medicines.
TAKE ACTION NOW!
What is the Campaign?
Médecins Sans Frontières set up the Access Campaign in 1999 to push for access to, and the development of life-saving and life prolonging medicines, diagnostic tests and vaccines for patients in MSF programmes and beyond. We are a multi-disciplinary team that includes doctors, pharmacists, scientists, lawyers, as well as advocacy and communications experts. We also work with patient groups and other civil society organisations in response to their concerns over access to treatment.
Stories from the Field
- » Snakebite in South Sudan: Little hope of a cure for the most vulnerable
- » South Sudan: The Book that Traveled Too Much
- » Guinea: Screening for HIV in Conakry
- » Pakistan: Stories from patients cured from hepatitis C in MSF's Machar Clinic in Karachi
- » Chechnya: New Treatment Regimens Giving Hope to XDR TB Patients
- » Yemen: antiretroviral treatment beneath the bombs